Ignite Creation Date:
2025-12-24 @ 11:49 PM
Ignite Modification Date:
2026-02-18 @ 5:57 AM
Study NCT ID:
NCT01513551
Status:
COMPLETED
Last Update Posted:
2018-12-13
First Post:
2011-12-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
The Safety, Tolerability, and Immunogenicity Profiles of a Single Dose of V114, PNEUMOVAX® 23, or PREVNAR 13® in Adults 50 Years of Age or Older (V114-002)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-03-13
Start Date Type:
ACTUAL
Primary Completion Date:
2013-02-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-02-15
Completion Date Type:
ACTUAL
First Submit Date:
2011-12-27
First Submit QC Date:
None
Study First Post Date:
2012-01-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-11-26
Results First Submit QC Date:
None
Results First Post Date:
2018-12-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-11-26
Last Update Post Date:
2018-12-13
Last Update Post Date Type:
ACTUAL